A team of EPFL engineers has developed technology that could partially restore vision in blind people. The study is published in Communications Materials.
In order to monitor and contain the spread of SARS-CoV-2 it is necessary to test large numbers of people on a regular basis in decentralized settings. […]
While chronic neurological effects from concussion have been widely studied, little is known about possible links between concussion and long-term medical and behavioral comorbidities. A retrospective […]
Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified […]